Disciplined Equity Management, Inc. Gilead Sciences, Inc. Transaction History

Disciplined Equity Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	SELL	$77.31 - $88.08 $2.12 Million - $2.41 Million	-27,386 Reduced 99.27%	200 $16,000
Q4 2022 Jan 13, 2023	SELL	$62.32 - $89.47 $2,492 - $3,578	-40 Reduced 0.14%	27,586 $2.37 Million
Q3 2022 Oct 14, 2022	SELL	$59.54 - $68.01 $2,977 - $3,400	-50 Reduced 0.18%	27,626 $1.7 Million
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $31,515 - $35,495	546 Added 2.01%	27,676 $1.71 Million
Q1 2022 Apr 27, 2022	BUY	$57.92 - $72.58 $1.57 Million - $1.97 Million	27,130 New	27,130 $1.61 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Disciplined Equity Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Disciplined Equity Management, Inc. with notifications on news.